These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 12581899)
1. A novel tumorigenic human prostate epithelial cell line (M2205): molecular cytogenetic characterization demonstrates C-MYC amplification and jumping translocations. Jackson-Cook C; Zou Y; Turner K; Astbury C; Ware J Cancer Genet Cytogenet; 2003 Feb; 141(1):56-64. PubMed ID: 12581899 [TBL] [Abstract][Full Text] [Related]
2. Stepwise genetic changes associated with progression of nontumorigenic HPV-18 immortalized human prostate cancer-derived cell line to a malignant phenotype. Hukku B; Mally M; Cher ML; Peehl DM; Kung H; Rhim JS Cancer Genet Cytogenet; 2000 Jul; 120(2):117-26. PubMed ID: 10942801 [TBL] [Abstract][Full Text] [Related]
3. Molecular cytogenetic analysis of a nontumorigenic human breast epithelial cell line that eventually turns tumorigenic: validation of an analytical approach combining karyotyping, comparative genomic hybridization, chromosome painting, and single-locus fluorescence in situ hybridization. Nielsen KV; Niebuhr E; Ejlertsen B; Holstebroe S; Madsen MW; Briand P; Mouridsen HT; Bolund L Genes Chromosomes Cancer; 1997 Sep; 20(1):30-7. PubMed ID: 9290951 [TBL] [Abstract][Full Text] [Related]
5. Amplification of C-MYC as the origin of the homogeneous staining region in ovarian carcinoma detected by micro-FISH. Abeysinghe HR; Cedrone E; Tyan T; Xu J; Wang N Cancer Genet Cytogenet; 1999 Oct; 114(2):136-43. PubMed ID: 10549271 [TBL] [Abstract][Full Text] [Related]
6. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping. Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C Cytogenet Cell Genet; 1999; 87(3-4):225-32. PubMed ID: 10702678 [TBL] [Abstract][Full Text] [Related]
7. Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor-forming potential in an early-stage prostate cancer epithelial subline (M2205). Paulraj P; Barrie E; Jackson-Cook C Mol Genet Genomic Med; 2024 Jan; 12(1):e2307. PubMed ID: 37902189 [TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051 [TBL] [Abstract][Full Text] [Related]
10. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer. Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591 [TBL] [Abstract][Full Text] [Related]
11. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Bae VL; Jackson-Cook CK; Maygarden SJ; Plymate SR; Chen J; Ware JL Prostate; 1998 Mar; 34(4):275-82. PubMed ID: 9496902 [TBL] [Abstract][Full Text] [Related]
12. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Qian J; Jenkins RB; Bostwick DG Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Macville M; Schröck E; Padilla-Nash H; Keck C; Ghadimi BM; Zimonjic D; Popescu N; Ried T Cancer Res; 1999 Jan; 59(1):141-50. PubMed ID: 9892199 [TBL] [Abstract][Full Text] [Related]
14. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63. Lim G; Karaskova J; Vukovic B; Bayani J; Beheshti B; Bernardini M; Squire JA; Zielenska M Cancer Genet Cytogenet; 2004 Sep; 153(2):158-64. PubMed ID: 15350306 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. Jackson-Cook C; Bae V; Edelman W; Brothman A; Ware J Cancer Genet Cytogenet; 1996 Mar; 87(1):14-23. PubMed ID: 8646734 [TBL] [Abstract][Full Text] [Related]
16. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Williams BJ; Jones E; Kozlowski JM; Vessella R; Brothman AR Genes Chromosomes Cancer; 1997 Apr; 18(4):299-304. PubMed ID: 9087570 [TBL] [Abstract][Full Text] [Related]
17. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Knutsen T; Rao VK; Ried T; Mickley L; Schneider E; Miyake K; Ghadimi BM; Padilla-Nash H; Pack S; Greenberger L; Cowan K; Dean M; Fojo T; Bates S Genes Chromosomes Cancer; 2000 Jan; 27(1):110-6. PubMed ID: 10564593 [TBL] [Abstract][Full Text] [Related]
18. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors. Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234 [TBL] [Abstract][Full Text] [Related]